CT导引下肝囊性病变穿刺抽吸引流和硬化治疗57例

目的: 探讨CT定位下经皮肝囊性病变穿刺抽吸引流和无水乙醇硬化治疗的疗效及其病理基础. 方法: 在CT导向下对57例共80个肝囊性病变进行穿刺抽吸或引流,根据囊肿性质进行相应的硬化治疗,并随访全部病例. 结果: 治疗后囊肿大小均有变化,囊肿较治疗前缩小1/3者6例,囊肿较治疗前缩小1/3～2/3者24例,囊肿消失者27例. 有效率100%,随访0.5～4 a未发现有复发者,无严重并发症出现. 结论: CT导向下经皮穿刺抽吸引流和注射无水乙醇硬化治疗肝囊性病变安全有效.

CT-guided percutaneous aspiration or drainage and sclerotherapy of 57 patients with hepatic cystic disease

AIM: To investigate the efficiency of percutaneous treatment of hepatic cystic disease by aspiration or drainage followed by CT-guided injection of alcohol and to study the pathologic basis.METHODS: Eighty hepatic cysts in 57 patients underwent CT-guided percutaneous puncture and aspiration.All the cases received corresponding ethanol sclerotherapy according to the different quality of the cysts and were followed up.RESULTS: Compared with those pre-sclerotherapy,the cysts reduced by less than 1/3 in 6 cases,by 1/3-2/3 in 24 cases and disappeared in 27 cases after sclerotherapy.The treatment was effective in all the cases.After 6 months to 4 years follow-up,no fatal complications or recrudescent cases were found.CONCLUSION: Percutaneous treatment of hepatic cystic disease by aspiration or drainage followed by CT-guided injection of alcohol is safe and effective.